ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    STUDY OF SERUM PCSK9 LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HAEMODIALYSIS.


    Dr. Hena Dhir, Dr. Richa Raj, Dr. Sude Kumar Singh, Dr. Alka Puria, Dr. Rajeev Kumar, Dr. Ekram Goyal
    JCDR. 2021: 3349 -3355

    Abstract

    Introduction: Chronic Kidney Disease is defined as presence of kidney damage or an estimated glomerular filtration rate (eGFR) less than 60ml/min/1.73mt2 persisting for 3 months or more. PCSK-9 (Proprotein convertase subtilisin/kexin type 9) is a new biomarker which has been observed to be raised in CKD patients.

    Description

    .

    » PDF

    Volume & Issue

    Volume 12 Issue 5

    Keywords